A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

A study reveals that a common genetic mutation doubles the risk of dementia in men, linking it to problems with iron ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

"You have frontotemporal dementia, you have Lewy Body dementia, the Korsakoff's dementia. So, there are lots of different ...